Montemac Plus Tablet is a combination medication containing bambuterol (10mg) and montelukast (10mg). It is indicated for the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and for the prevention of exercise-induced bronchospasm (EIB). Bambuterol, a selective beta-2 agonist, provides bronchodilation and improves lung function, while montelukast, a leukotriene receptor antagonist, inhibits the production of leukotrienes, which are inflammatory mediators. The combination of these two medications provides a synergistic effect in reducing bronchospasm and inflammation. The tablet is available in a once-daily dosage form and is suitable for patients who require a bronchodilator and an anti-inflammatory medication. Montemac Plus Tablet has a rapid onset of action and a long duration of action, making it an effective treatment option for patients with COPD and EIB. As with any medication, patients should follow the recommended dosage and consult with their healthcare provider if they experience any adverse effects.